Light chain deposition disease developing 15 years following the diagnosis of monoclonal gammopathy of undetermined significance

Internal Medicine

Volumn 48, Issue 2, 2009, Pages 101-104

  Okura, Takafumi ^a   Miyoshi, Ken Ichi ^a   Nagao, Tomoaki ^a   Jotoku, Masanori ^a   Enomoto, Daijiro ^a   Irita, Jun ^a   Kurata, Mie ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Light chain deposition disease; Monoclonal gammopathy of undetermined significance; Nephrotic syndrome

Indexed keywords

ALBUMIN; AMLODIPINE; ATORVASTATIN; BENCE JONES PROTEIN; CHOLESTEROL; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN KAPPA CHAIN; LOSARTAN; MELPHALAN; PREDNISOLONE;

ADULT; ARTICLE; BASEMENT MEMBRANE; BONE MARROW BIOPSY; CAPILLARY WALL; CASE REPORT; CELL PROLIFERATION; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMMUNOELECTROPHORESIS; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; LABORATORY TEST; LEG EDEMA; LIGHT CHAIN DEPOSITION DISEASE; MESANGIUM CELL; MONOCLONAL IMMUNOGLOBULINEMIA; NEPHROTIC SYNDROME; PLASMACYTOSIS; PROTEINURIA; EDEMA; IMMUNOLOGY; KIDNEY DISEASE; LEG; MESANGIUM; MIDDLE AGED; PARAPROTEINEMIA; PATHOLOGY; TIME; URINE;

EDEMA; FEMALE; GLOMERULAR MESANGIUM; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN KAPPA-CHAINS; KIDNEY DISEASES; LEG; MIDDLE AGED; PARAPROTEINEMIAS; TIME FACTORS;

EID: 61749084044     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1679     Document Type: Article

References (11)

1. Randall RE, Williamson WC Jr, Mullinax F, Tung MY, Still WJ. Manifestations of systemic light chain deposition. Am J Med 60: 293-299, 1976.
2. Tubbs RR, Gephardt GN, McMahon JT, Hall PM, Valenzuela R, Vidt DG. Light chain nephropathy. Am J Med 71: 263-269, 1981.
3. Pozzi C, D'Amico M, Fogazzi GB, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 42: 1154-1163, 2003.
4. Buxbaum JN, Chuba JV, Hellman GC, Solomon A, Gallo GR. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med 112: 455-464, 1990.
5. Kyle RA. Monoclonal gammopathy of undetermined significance. Blood Rev 8: 135-141, 1994.
6. Paueksakon P, Revelo MP, Horn RG, Shappell S, Fogo AB. Monoclonal gammopathy: significance and possible causality in renal disease. Am J Kidney Dis 42: 87-95, 2003.
7. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775-788, 1974.
8. Jensen H, Wiik A. Monoclonal immunoglobulinaemia associated with glomerulopathy. Acta Med Scand 197: 265-269, 1975.
9. Kyle RA, Remstein ED, Therneau TM, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 356: 2582-2590, 2007.
10. Joh K. Pathology of glomerular deposition diseases. Pathol Int 57: 551-565, 2007.
11. Heilman RL, Velosa JA, Holley KE, Offord KP, Kyle RA. Longterm follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis 20: 34-41, 1992.